The small cell lung cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $10.87 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to investments in research and development activities for small cell lung cancer treatments, rising toboco smoking, growing chemotherapy, increasing healthcare expenditure. Major trends in the forecast period include advances in early detection and screening methods, clinical trial expansion, advances in radiation therapy, immunotherapy advancements.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report
Scope Of Small Cell Lung Cancer Therapeutics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Small Cell Lung Cancer Therapeutics Market Overview
Market Drivers –
The increasing prevalence of lung cancer is expected to propel the growth of the small-cell lung cancer therapeutics market going forward. Lung cancer is a malignant disease with symptoms such as coughing, chest pain and difficulty breathing that is defined by the unchecked proliferation of abnormal cells in the lung tissues. Treatment for lung cancer, including small cell lung cancer, usually involves a combination of chemotherapy, radiation therapy and, in some cases, targeted therapies that provide prolonged survival and improved quality of life for lung cancer patients. For instance, in January 2023, according to the American Cancer Society, a US-based government organization, there were approximately 238,340 new cases of lung cancer (117,550 in men and 120,790 in women) and reportedly 127,070 deaths from lung cancer (67,160 in men and 59,910 in women) in 2022. Therefore, the rise in the prevalence of lung cancer is driving the growth of the small-cell lung cancer therapeutics market.
Market Trends –
Major companies operating in small-cell lung cancer therapeutics are focused on developing new drugs to gain competitive advantages and strengthen their position in the market. For instance, in February 2021, G1 Therapeutics Inc., a US-based oncology company, launched COSELA (trilaciclib) for small cell lung cancer therapeutics, which was approved by the Food and Drug Administration (FDA), a US-based government agency. It is an injection to reduce the risk of chemotherapy-induced myelosuppression in adult patients receiving a platinum/etoposide- or topotecan-containing regimen for advanced small cell lung cancer (ES-SCLC). Additionally, it is the first and only medicine made to help protect bone marrow (myeloprotection) when given before chemotherapy treatment.
The small cell lung cancer therapeutics market covered in this report is segmented –
1) By Drug Type: Atezolizumab; Topotecan; Lurbinectedin; Durvalumab; Methotrexate; Pembrolizumab
2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
4) By End-Users: Hospitals; Cancer Therapy Centers; Other End-Users
Get an inside scoop of the small cell lung cancer therapeutics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12912&type=smp
Regional Insights –
North America was the largest region in the small cell Lung cancer therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small cell lung cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the small cell lung cancer therapeutics market are Pfizer Inc., Johnson and Johnson Private Limited, F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Janssen Pharmaceuticals, Novartis AG, Merck and Co. Inc., Sanofi S.A, Bristol-Myers Squibb Company, Astrazeneca PLC, GSK PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Vertex Pharmaceuticals, Aurobindo Pharma Limited, Kyowa Kirin Co. Ltd.
Table of Contents
1. Executive Summary
2. Small Cell Lung Cancer Therapeutics Market Report Structure
3. Small Cell Lung Cancer Therapeutics Market Trends And Strategies
4. Small Cell Lung Cancer Therapeutics Market – Macro Economic Scenario
5. Small Cell Lung Cancer Therapeutics Market Size And Growth
…..
27. Small Cell Lung Cancer Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/carotenoids-market-size/
https://goodprnews.com/aircraft-seat-upholstery-market-share/
https://goodprnews.com/rice-polisher-market-size/
https://topprnews.com/carotenoids-market-share/
https://topprnews.com/aircraft-seat-upholstery-market-size/
https://topprnews.com/rice-polisher-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
